NDC product
Dermoplast Pain relieving
NDC 16864-690 · Advantice Health
Key facts
| Product NDC | 16864-690 |
|---|---|
| Proprietary name | Dermoplast Pain relieving |
| Nonproprietary name | BENZOCAINE, MENTHOL |
| Substances | BENZOCAINE, MENTHOL |
| Dosage form | SPRAY |
| Route | TOPICAL |
| Labeler | Advantice Health |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M017 |
| Pharmacologic classes | Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC] |
| Marketing start | Mar 18, 2022 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: